DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,799,000 | -62.0% | 220,400 | -37.0% | 0.05% | -29.7% |
| Q2 2021 | $7,364,000 | +35.5% | 350,000 | 0.0% | 0.07% | +45.1% |
| Q1 2021 | $5,436,000 | -26.0% | 350,000 | 0.0% | 0.05% | -20.3% |
| Q4 2020 | $7,350,000 | +4.0% | 350,000 | 0.0% | 0.06% | -28.1% |
| Q3 2020 | $7,067,000 | – | 350,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $104,175,000 | 19.37% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,280,000 | 15.62% |
| Logos Global Management LP | 2,054,392 | $43,224,000 | 3.63% |
| GREAT POINT PARTNERS LLC | 672,559 | $14,151,000 | 2.97% |
| Octagon Capital Advisors LP | 583,649 | $12,280,000 | 2.54% |
| COMMODORE CAPITAL LP | 305,125 | $6,420,000 | 2.24% |
| RA Capital Management | 2,805,045 | $59,018,000 | 0.95% |
| Altium Capital Management LP | 166,636 | $3,506,000 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 135,000 | $2,840,000 | 0.75% |
| Soleus Capital Management, L.P. | 178,360 | $3,753,000 | 0.58% |